This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (15)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Ataxia  • Neurogenetics  • Parkinson Disease/ Parkinsonian Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Chin-Song Lu, MD; Yah-Huei Wu Chou, PhD; Pei-Chi Kuo, BS; Hsiu-Chen Chang, BS; Yi-Hsin Weng, MD

Arch Neurol. 2004;61:35-38.

Background  We recently reported that spinocerebellar ataxia type 2 (SCA2) caused familial parkinsonism in 2 brothers with predominant symptoms of resting tremor, rigidity, and bradykinesia that responded to levodopa.

Objective  To investigate SCA2 as the possible cause of familial parkinsonism in our series and subsequently to analyze the correlation between the clinical manifestation and CAG repeat size in the ataxin-2 gene product.

Patients  One hundred thirty patients from 41 families with familial parkinsonism were examined for SCA2. Another 8 patients with the classic ataxic phenotype of SCA2 from 6 families were the control group.

Design  The length of expanded CAG repeat was analyzed by means of polymerase chain reaction. The clinical data and genetic findings in the parkinsonian phenotype were then compared with those in the ataxic phenotype.

Results  We found expanded CAG repeats in the ataxin-2 gene product in 7 patients from 4 families with parkin-sonism, which was about 10% of our familial parkinsonism series. The parkinsonian phenotype was characterized by resting tremor, rigidity, and bradykinesia. Only mild dysarthria, ataxic gait, and instability were noted, particularly in the late stage. Patients with the parkinsonian phenotype had an older mean ± SD age of symptom onset (45.8 ± 13.9 years) and shorter mean ± SD abnormal CAG length (36.2 ± 1.1 repeats) than did those with the ataxic phenotype (26.9 ± 11.0 years and 43.1 ± 3.2 repeats). Parkinsonian SCA2 responded well to levodopa.

Conclusions  We conclude that SCA2 is a minor cause of familial parkinsonism, particularly in Taiwan. The parkinsonian phenotype is associated predominantly with a shorter abnormal range of CAG repeat lengths and older onset age. Because of the clinical resemblance among familial parkinsonisms, we suggest that SCA2 should be excluded in cases of familial parkinsonism.

From the Movement Disorders Unit, First Department of Neurology (Drs Lu, Kuo, Chang, and Weng) and Human Molecular Genetics Laboratory (Dr Wu Chou), Chang Gung Memorial Hospital and School of Medicine, Chang Gung University, Lin-Ko, Taipei, Taiwan.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

When Is Ataxia Not Ataxia?
Katrina Gwinn-Hardy
Arch Neurol. 2004;61(1):25-26.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Parkinson's disease: from monogenic forms to genetic susceptibility factors
Lesage and Brice
Hum Mol Genet 2009;18:R48-R59.
ABSTRACT | FULL TEXT  

Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?
Charles et al.
Neurology 2007;69:1970-1975.
ABSTRACT | FULL TEXT  

Importance of Low-Range CAG Expansion and CAA Interruption in SCA2 Parkinsonism
Kim et al.
Arch Neurol 2007;64:1510-1518.
ABSTRACT | FULL TEXT  

Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes
Satterfield and Pallanck
Hum Mol Genet 2006;15:2523-2532.
ABSTRACT | FULL TEXT  

When Is Ataxia Not Ataxia?
Gwinn-Hardy
Arch Neurol 2004;61:25-26.
FULL TEXT